RecruitingNCT06373055

Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics

Studying Muscular tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yonsei University
Principal Investigator
Won Sik Ham
Department of Urology and Urological Science Institute, Yonsei University College of Medicine Seoul, Republic of Korea
Intervention
neoadjuvant chemotherapy followed by radical cystectomy(other)
Enrollment
250 enrolled
Eligibility
18-80 years · All sexes
Timeline
20242033

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06373055 on ClinicalTrials.gov

Other trials for Muscular tumor

Additional recruiting or active studies for the same condition.

See all trials for Muscular tumor

← Back to all trials